Clinical Trial Update: PDE3B in Metabolic Regulation

View source ↗

Summary

A clinical trial update indicates a study evaluating PDE3B in metabolic regulation is currently enrolling by invitation, focusing on type 2 diabetes mellitus an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Metabolic Syndrome
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Cambridge University Hospitals NHS Foundation Trust | Conditions: Type 2 Diabetes, Cardiometabolic Syndrome | Status: ENROLLING_BY_INVITATION